Ameriprise’s MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% MSK.CL Stock Holding History

Ameriprise’s Portfolio MSK.CL Stock Details MSK.CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,499	Closed	-$241K	–	3919
2016 Q2	$241K	Buy	9,499 +1,063	+13%	+$27.3K	﹤0.01%	3473
2016 Q1	$216K	Buy	+8,436	New	+$215K	﹤0.01%	3509
2014 Q4	–	Sell	-1,677	Closed	-$42K	–	4968
2014 Q3	$42K	Buy	1,677 +617	+58%	+$15.6K	﹤0.01%	4101
2014 Q2	$27K	Buy	1,060 +160	+18%	+$4.04K	﹤0.01%	4188
2014 Q1	$23K	Buy	900 +300	+50%	+$7.47K	﹤0.01%	4147
2013 Q4	$14K	Buy	600 +400	+200%	+$9.78K	﹤0.01%	4236
2013 Q3	$5K	Hold	200	–	–	﹤0.01%	5253
2013 Q2	$5K	Buy	+200	New	+$5.04K	﹤0.01%	5161

Other funds holding MSK.CL

BCM

Beddow Capital Management Jackson, Wyoming $265M AUM 18.36% 1-Year Est. Return

Ameriprise's MSK.CL Position: Q3 2016 in Review

Ameriprise sold out of MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% (MSK.CL) in Q3 2016, closing a stake of 9,499 shares — an estimated $241K sold.

Ameriprise first reported a position in MSK.CL in Q2 2013 and held it in 8 quarters. The position peaked at $241K in Q2 2016. 1 fund tracked by Wall St. Rank holds MSK.CL as of Q3 2016.

Ameriprise reported no remaining MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% position as of Q3 2016 after selling out during the quarter.
Ameriprise sold 9,499 MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% shares in Q3 2016, an estimated $241K.
Ameriprise first reported a position in MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% in Q2 2013 and held it in 8 quarters.
Ameriprise's MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% position peaked at $241K in Q2 2016.
1 fund tracked by Wall St. Rank held MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% as of Q3 2016.

Based on Ameriprise's 13F filing for Q3 2016, filed 8 Nov 2016.